Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 19 | 21 | +2 |
| Shares | 1.23M | 1.28M | +49.3K (+4.0%) |
| Value | $3.15M | $5.50M | +$2.36M (+75.0%) |
New holders (5)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 17,049 | $73.0K | 0.00% |
| Charles Schwab Investment Management Inc | 11,609 | $50.0K | 0.00% |
| NorthRock Partners, LLC | 10,000 | $43.0K | 0.00% |
| UBS Group AG | 4,390 | $19.0K | 0.00% |
| Benjamin F. Edwards & Company, Inc. | 1,000 | $4.00K | 0.00% |
Sold out (3)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Virtu Financial LLC | 31,038 | $79.0K |
| Golden Green, Inc. | 24,700 | $63.0K |
| Citadel Advisors LLC | 20,198 | $52.0K |